Lung Cancer After Hodgkin’s Disease: A Nested Case-Control Study of the Relation to Treatment
Anthony J. Swerdlow(Institute of Cancer Research), David C. Linch(University of Oxford), Julie Barber(University College London), David Cunningham(Royal Marsden NHS Foundation Trust), Alan Horwich(Institute of Cancer Research), R. Allerton, T. Andrew Lister(St Bartholomew's Hospital), A. Z. S. Rohatiner(Institute of Cancer Research), Minouk J. Schoemaker(Institute of Cancer Research), G. Vaughan Hudson(Institute of Cancer Research), M. V. Williams(Institute of Cancer Research)
Cited by 132
Related Papers
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
|New England Journal of Medicine|2010|4.5k
Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
|New England Journal of Medicine|2008|2.3k
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
|Science|2018|2.1k